OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor
Burkhard Tümmler
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Burkhard Tümmler
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Showing 15 citing articles:
Human Mesenchymal Stem Cell Therapy: Potential Advances for Reducing Cystic Fibrosis Infection and Organ Inflammation
Tracey L. Bonfield, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025), pp. 101602-101602
Closed Access
Tracey L. Bonfield, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025), pp. 101602-101602
Closed Access
Inhalation of SP-101 followed by inhaled doxorubicin results in robust and durable hCFTRΔR transgene expression in the airways of wild-type and cystic fibrosis ferrets
Katherine J. D. A. Excoffon, Mark Bodman‐Smith, Lillian Falese, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 17-18, pp. 710-725
Closed Access | Times Cited: 4
Katherine J. D. A. Excoffon, Mark Bodman‐Smith, Lillian Falese, et al.
Human Gene Therapy (2024) Vol. 35, Iss. 17-18, pp. 710-725
Closed Access | Times Cited: 4
Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies
Eline Cauwenberghs, Ilke De Boeck, Irina Spacova, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101371-101371
Open Access | Times Cited: 3
Eline Cauwenberghs, Ilke De Boeck, Irina Spacova, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101371-101371
Open Access | Times Cited: 3
Decatastrophizing research irreproducibility
Michael F. Jarvis
Biochemical Pharmacology (2024) Vol. 228, pp. 116090-116090
Closed Access | Times Cited: 3
Michael F. Jarvis
Biochemical Pharmacology (2024) Vol. 228, pp. 116090-116090
Closed Access | Times Cited: 3
Antimicrobial peptide glatiramer acetate targets Pseudomonas aeruginosa lipopolysaccharides to breach membranes without altering lipopolysaccharide modification
Ronan A. Murphy, Jade Pizzato, Leah Cuthbertson, et al.
npj Antimicrobials and Resistance (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Ronan A. Murphy, Jade Pizzato, Leah Cuthbertson, et al.
npj Antimicrobials and Resistance (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Deepak Joshi, Jeremy Nayagam, Lisa Clay, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 7, pp. 812-842
Closed Access | Times Cited: 2
Experimental pharmacology in precision medicine
Alicja Urbaniak, Kenneth E. Thummel, Ayoade N. Alade, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 4
Alicja Urbaniak, Kenneth E. Thummel, Ayoade N. Alade, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 4
CFTR dysfunction leads to defective bacterial eradication on cystic fibrosis airways
Min Wu, Jeng‐Haur Chen
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 1
Min Wu, Jeng‐Haur Chen
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 1
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Targeted Therapeutics for Cystic Fibrosis
Diana‐Florentina Veselu, Han‐I Yeh, Mayuree Rodrat, et al.
Springer eBooks (2024), pp. 239-284
Closed Access | Times Cited: 1
Diana‐Florentina Veselu, Han‐I Yeh, Mayuree Rodrat, et al.
Springer eBooks (2024), pp. 239-284
Closed Access | Times Cited: 1
Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: Current and future challenges
Rebecca Dobra, Sarah Carroll, Jane C. Davies, et al.
Paediatric Respiratory Reviews (2024)
Open Access | Times Cited: 1
Rebecca Dobra, Sarah Carroll, Jane C. Davies, et al.
Paediatric Respiratory Reviews (2024)
Open Access | Times Cited: 1
Mukoviszidose: Management im Zeitalter der CFTR-Modulator-Therapie
Burkhard Tümmler
Pädiatrie up2date (2024) Vol. 19, Iss. 01, pp. 13-28
Closed Access
Burkhard Tümmler
Pädiatrie up2date (2024) Vol. 19, Iss. 01, pp. 13-28
Closed Access
The ageing of people living with cystic fibrosis: what to expect now?
Almudena Felipe Montiel, Antonio Álvarez Fernández, Mario Culebras Amigo, et al.
European Respiratory Review (2024) Vol. 33, Iss. 174, pp. 240071-240071
Open Access
Almudena Felipe Montiel, Antonio Álvarez Fernández, Mario Culebras Amigo, et al.
European Respiratory Review (2024) Vol. 33, Iss. 174, pp. 240071-240071
Open Access
Measurement of treatment burden in cystic fibrosis: A systematic review
Rana Altabee, Martin J Mwamba, David Turner, et al.
Journal of Cystic Fibrosis (2024)
Open Access
Rana Altabee, Martin J Mwamba, David Turner, et al.
Journal of Cystic Fibrosis (2024)
Open Access
Therapeutic effect of CFTR modulators in cystic fibrosis patients with the 2789+5G>A splice variant in the genotype
Maria Krasnova, Anna Efremova, Yu. L. Melyanovskaya, et al.
PULMONOLOGIYA (2024) Vol. 34, Iss. 6, pp. 857-868
Open Access
Maria Krasnova, Anna Efremova, Yu. L. Melyanovskaya, et al.
PULMONOLOGIYA (2024) Vol. 34, Iss. 6, pp. 857-868
Open Access
Cystic Fibrosis: From Salty Malediction to Possible Cure
Amparó Solé, Jane C. Davies, Esther Quintana‐Gallego
Archivos de Bronconeumología (2023) Vol. 60, Iss. 3, pp. 129-130
Closed Access
Amparó Solé, Jane C. Davies, Esther Quintana‐Gallego
Archivos de Bronconeumología (2023) Vol. 60, Iss. 3, pp. 129-130
Closed Access
